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SUMMARY
Atypical glandular cells are a common finding in cervical cytology in cervical cancer 
screening and its occurrence has increased in the last decades. The identification of these 
cells is clinically very important due to its association with cervical and endometrial 
dysplasic lesions and cancer. Using a systematic approach, this article reviewed studies 
investigating cervical lesions that are characteristic in patients previously diagnosed as 
having atypical glandular cells. Studies in which diagnostic investigation did not include 
histopathological diagnosis were excluded. A comprehensive search for available mate-
rial in LILACS, SciELO, PubMed/ Medline and Old Medline databases, dated between 
1966 and 2009 was performed. Articles omitted by the electronic database search were 
also included. Nineteen articles met the inclusion criteria and were selected. This report 
aims at evaluating whether atypical glandular cells, initially found in cervical cytology 
and subsequently identified at the histological analysis, are related to the presence of 
benign, pre-malignant and malignant lesions. Eleven out of 19 selected articles showed 
the highest correlation between atypical glandular cells with benign diseases and six with 
squamous pre-malignant lesions.
Keywords: Cervix neoplasm prevention; glandular and epithelial neoplasms; cervical 
intraepithelial neoplasia; review.
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INTRODUCTION
In 1988, when the Bethesda System classification was in-
troduced, the diagnostic category atypical glandular cells 
of undetermined significance (AGUS) was created1-4. In 
2001, when the second review of the Bethesda System was 
carried out, the term AGUS was substituted by atypical 
glandular cells (AGC), mainly due to the fact that it was 
mistaken for ASCUS (atypical squamous cells of undeter-
mined significance)1,3. These glandular atypias, when their 
location is not specified, are defined as cells with nuclear 
alterations that exceed the reactive or reparative processes, 
but which do not exhibit anaplasia characteristic of adeno-
carcinomas1-3. 
The finding of squamous atypia of the cervix at cyto-
logical analysis is ten times more frequent than glandular 
atypias1. The AGC category in cervicovaginal smears is a 
cytological finding in the routine screening for cervical 
cancer that has increased in the last decades, although it is 
still unusual in cytological diagnostics3,5,6.  
 In the literature, the report of AGC incidence ranges 
from 0.1% to 2.1%4. The verification of this atypia is clini-
cally important, as the percentage of cases associated with 
high-degree cervical and endometrial disease and neo-
plasms is higher than that for ASCUS3,6. In fact, 9% to 38% 
of the women with AGC have significant lesions (CIN2, 
CIN3 and in situ adenocarcinoma) and 3% to 17% have 
invasive carcinomas3. 
The diagnosis of atypical glandular cells of undeter-
mined significance is an exclusion diagnosis7. The lesions 
must be then classified as that, if they cannot be included 
in the categories of benign, pre-neoplastic or malignant le-
sion7,8. The histological results of AGC in Pap smears are so 
broad that they include benign lesions and neoplastic al-
terations of squamous and glandular cells9.  The American 
Society of Colposcopy and Cervical Pathology (ASCCP), 
as well as the Ministry of Health in Brazil, indicates the im-
mediate colposcopic analysis with endocervical sampling 
for cases of AGC1,5,6. 
 This article aimed to verify the profile of uterine cervi-
cal lesions in patients with a previous cytological diagnosis 
of atypical glandular cells through a systematic review of 
medical literature, with the objective of identifying its as-
sociation with other diseases and/or lesions.   
METHODS
This review included articles selected from journals in-
dexed at the LILACS, SciELO, PubMed/ Medline and Old 
Medline databases, from 1966 to 2009. The keywords used 
in the search were based on the MeSH and DeCS lists. 
The following terms were chosen for the search: atypical 
glandular cells, uterine cancer and precancerous lesions. 
Combinations were used for the search in all databases. 
The references found in the chosen articles were also veri-
fied, in order to identify other studies that might have been 
omitted in the electronic search. The titles and summaries 
were analyzed for potentially relevant articles. No limita-
tions were considered during the search and the articles 
were subsequently selected by inclusion and exclusion cri-
teria. The chosen publications were obtained for the reas-
sessment of their results. 
Studies that investigated patients with positive cytol-
ogy for glandular cell atypia and followed histopatho-
logical diagnosis were included in the review. The histo-
pathological analysis considered the presence of benign 
reactive processes and histologically significant lesions, 
such as squamous and glandular, cervical and endometrial 
neoplasias, as well as neoplasias from other sites. In this 
review, patient age was not used as a screening criterion, 
as well as the morphological criteria used to attain the re-
ported diagnoses. Studies in which diagnosis was not at-
tained through histopathological analysis, the number of 
biopsies was omitted and review articles were excluded.
RESULTS
The selected articles identified through electronic search 
comprehended the period from 1992 to 2009, which were 
recovered in full length for a more detailed analysis. Re-
peated articles were considered in only one search source. 
A total of 38 articles were reported by the databases and 
four were selected for the review. 
Through reference analysis, 13 publications initially 
omitted in the electronic search were identified, and two 
studies were identified in random searches, totaling 19 ar-
ticles (Table 1).  
The number of cytological analyses with AGC in the 
reviewed articles varied from 4410 to 1,11711, with an in-
cidence of 0.05% to 2.1%. Only one publication showed a 
higher incidence (6%)12. The percentage of histopathologi-
cal analyses carried out in the patients com atypia ranged 
from 17%13 to 100%10,14,15. Among the 19 reviewed articles, 
a predominance of benign lesions was demonstrated in 
11 and pre-malignant squamous lesions in 6 articles. In 
two articles, the percentage of benign and pre-malignant 
pathologies was the same (43% and 42%)16,17. Invasive le-
sions reported by the reviewed articles showed that the 
percentage of invasive squamous carcinoma ranged from 
0.89%5 to 4.44%15 and cervical adenocarcinoma ranged 
from 1.4%18 to 18%5. Only one report did not describe an 
association with malignant lesion10. 
DISCUSSION
The Bethesda System classification (1988) included the di-
agnoses related to atypical glandular cells in the cytologi-
cal assessment classification of the uterine cervix. Since 
then, the presence and assessment of endocervical cells 
has been taken into account in cytological smears1,2,3. In 
1991, at the first review of the Bethesda System, the ab-
breviation AGUS was introduced to represent this lesion3. 
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Table 1 – AGC study results with histological correlation
Author/year Incidence
Patients with 
histopathological 
diagnosis 
SIL
Invasive 
squamous
carcinoma 
Cervical 
adenocarcinoma 
Endometrial 
adenocarcinoma 
Benign 
pathology/
normal
Others
Goff et al., 
1992 10
100/21.930 
(0. 46%)
56/100 
(56%)
19/56 
(34%)
0 7/56 
(12.5%)
0 24/56 
(42.85%)
6/56 
(10.7%)
Nasu et al., 
199311
 620/34.384 
(1.8%) 
279/620 
(45%)
140/279 
(50.17%)
4/279 
(1.43%)
14/279 
(5%)
4/279 
(1.43%)
114/279 
(40.86%)
3/279 
(1%)
Bose et al., 
199412
44 44 
(100%)
35/44 
(80%)
0 0 0 9/44 
(20%)
0
Lee et al., 
1995 13
210/79.942 
(0.26%)
74/210 
(35.2%)
33/74 
(44.5%)
0 10/74 
(13.5%)
0 31/74 
(42%)
0
Jones e 
Novis, 
199614
293/22.439 
(1.3%)  
AGUS
293/293 
(100%)
116/293 
(40%)
0 13/293  
(4.5%)
0 141/293  
(48%)
23/293 
(7.84%)
Kennedy et 
al., 199615
136/68.368 
(0.2%)  
AGUS
53/136 
(38.97%)
7/53 
(13.2%)
0 5/53 
(9.4%)
1/53 
(1.89%)
37/53 
(69.8%)
3/53 
(5.66%)
Eddy et al, 
199716
1.117/177.715 
(0.63%) 
AGUS
531/1.117 
(48%)
143/531 
(27%)
0 11/531 
(2%)
28/531 
(5%)
337/531  
(63%)
12/531 
(2.25%)
Raab et al., 
199717
346 
AGUS
116/346 
(33.5%)
50/116 
(43%)
0 5/116 
(4%)
11/116 
(9%)
50/116  
(43%)
0
Duska et al., 
1998 18
201/120.338 
(0.17%)  
AGUS
73/201 
(36.3%)
19/73 
(26%)
0 1/73  
(1.4%)
3/73  
(4%)
45/73  
(61.6%)
5/73 
(6.8%)
Veljovich et 
al., 199819
345/84.442 
(0.53%) 
AGUS
199/345 
(57.7%)
45/199 
(23%)
0 5/199 
(2.5%)
2/199 
(1%)
134/199 
(67%)
13/199 
(6.5%)
Burja et al., 
199920
377/ 18.198 
(2.1%) 
AGUS
64/377  
(17%)
35/64 
(54%)
0 3/64 
(5%)
0 26/64  
(41%)
0
Ronnett et 
al., 199921
225/46.009 
(0.5%) 
AGUS
136/225 
(60.44%)
23/136 
(17%)
0 3/136 
(2.20%)
1/136 
(0.73%)
109/136 
(80.14%)
0
Geier et al., 
200122
492/8.221 
(6%) 
AGUS
353/492 
(71.74%)
108/353 
(31%)
0 9/353 
(2.6%)
1/353 
(0.2%)
227/353 
(64%)
8/353 
(2.27%)
Hammoud et 
al., 20024 
207/ 208.041 
(0.1%)  
AGUS
114/207 
(60.3%)
28/114 
(24%)
0 4/114 
(3.5%)
11/114 
(10%)
66/114 
(57.8%)
5/114 
(4.4%)
Verdiani et 
al., 20032
443/217.245 
(0.2%) 
AGC
102/443 
(23.02%)
51/102  
(50%)
2/102 
(1.96%)
7/102 
(6.87%)
1/102 
(0.98%)
40/102 
(39.21%)
1/102 
(0.98%)
Gutman et 
al., 200423
45 /11.800 
(0.38%) 
AGUS
45/45 
(100%)
28/45  
(62%)
2/45 
(4.44%)
1/45 
(2.22)
0 14/45  
(31%)
0
Scheiden et 
al., 2004 24
261/566.809 
(0.05%)  
AGC
183/261 
(70.2%)
28/183  
(15%)
3/183 
(1.6%)
13/183 
(7.2%)
53/183 
(29%)
80/183 
(44%)
6/183 
(3.27%)
Westin et al., 
2008 25
155  
AGC
126/155 
(81.3%)
53/126  
(42%)
3/126 
(2.4%)
17/126 
(13.5%)
0 53/126 
(42%)
0
Zhao et al., 
20095
525/64.378 
(0.8%)   
AGC
460/525 
(87.6%)
32/460 
(28.57)
1/460 
(0.89%)
19/460 
(18%)
30/460 
(27%)
348/460  
(75.6%)
30/460 
(6.5%)
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The first publications (1992 to 1995) did not use the ab-
breviation AGUS, using the terms endocervical glandular 
atypia19,20, abnormal endocervical cells10 and atypical glan-
dular cells21. From 1996 onward, the articles used the term 
AGUS11-14,16,18,22-24, which was used until the review of the 
Bethesda System in 2001, when the term AGC started to 
be used2,5,17,25. The publications from 20024 and 200415 still 
used the term AGUS. 
The results depicted in Table 1 show that there is a 
small number of publications that correlate the presence 
of AGC with histopathological alterations. The finding of 
squamous atypias of the cervix in cytology is ten times 
more frequent when compared with glandular atypias, re-
sulting in a decreased volume of information available in 
the literature on cytological alterations1. 
Most studies shown in Table 1 were published between 
1992 and 1999. The 1992 publication19 is noteworthy, as it 
is the first one to report the findings of atypical endocer-
vical cells in the cytological screening of the cervix. The 
other studies were published between 2001 and 2009. 
The investigations evaluated a total of distinct cervico-
vaginal smears, resulting in a dierent amount of AGC di-
agnoses, which varied from 4410 to 1,11711. The incidence 
of cases with AGC varied from 0.05%25 to 2.1%13 in the 19 
articles, showing that there was an increase in incidence 
in the last decades13. The 2001 publication recorded a 
percentage of glandular atypia diagnosis of 6%12 (492 pa-
tients), being outside the range reported in the literature. 
Three reports10,16,17 did not record the percentage of AGC 
cases, as the total number of smears was not reported. The 
percentage of histopathological follow-up ranged among 
the authors from 17%13 to 100%10,14,15. It was observed that 
in cases that had 100%, the percentage was independent 
from the number of samples, varying from small10, 15 to 
larger samples14.
The present review evaluated the percentage of in-
traepithelial squamous cell lesions, invasive squamous 
carcinoma, cervical and endometrial adenocarcinoma, 
emphasizing the percentage of benign lesions. In six ar-
ticles a predominance of intraepithelial squamous cell le-
sions was evident. The highest percentage of these lesions 
was of 80%10, and the lowest, of 13.2%22. In the report by 
Bose et al.10, among the intraepithelial squamous cell le-
sions, 17 were low-grade and 18 were high-grade. A weak 
point of this report, which showed this high incidence, was 
the small sample size (44 patients). 
Of the significant histological alterations found in 
AGC cases, 12% to 46% had glandular origin. Howev-
er, most of the studies describe the squamous lesions, 
mainly the high- and low-grade intraepithelial lesions, as 
the ones found with higher frequencies (9% to 54%)26. 
Invasive squamous carcinoma was diagnosed through a 
histopathological analysis in patients with AGC in six ar-
ticles2,5,15,17,20,25, of which five were published from 2003 to 
2009. The incidence ranged from 1.43%20 to 4.4%15, being 
part of the clinically significant diagnoses. The study by 
Nasu et al.20, carried out with 279 patients, showed the 
lowest percentage of invasive squamous cell carcinoma 
of this review. The diagnosis for cervical adenocarci-
noma was realized in all articles, with a variable rate of 
1.4%18-18%5. The rates of endometrial adenocarcinoma 
varied from 0.2%22 to 29%25 were observed in 12 articles. 
Two publications that reported a higher number of ad-
enocarcinomas are worth mentioning. Scheiden et al.25 
diagnosed 13 adenocarcinomas of cervix, of which four 
were adenocarcinomas in situ and nine invasive adeno-
carcinomas. Of the 53 endometrial lesions, three were 
adenocarcinomas in situ and 50 were invasive adenocar-
cinomas. Zhao et al.5 showed 49 cervical and endometrial 
adenocarcinomas found in the histopathological analysis 
of 460 patients with AGC. 
According to Table 1 the incidence, at the histopatho-
logical analysis, of the findings considered as benign and/
or normal lesions varied from 20%10 to 80.14%24. Among 
the benign lesions, the most frequently reported ones were 
cervicitis, endocervical and endometrial polyps, tubal 
metaplasia, microglandular hyperplasia, endometrial hy-
perplasia and cervical leiomyomas. Some analyses ruled 
out the presence of other pre-neoplastic and neoplas-
tic lesions. The 2009 study5 reported 20 cases of atypical 
complex endometrial hyperplasia, two malignant mixed 
mullerian tumors, two cases of trophoblastic gestational 
diseases and six ovarian carcinomas. The other studies re-
vealed, as well as the aforementioned lesions, the presence 
of teratoma, Brenner tumor and uterine sarcoma, in addi-
tion to metastatic neoplasias. 
CONCLUSION
This systematic review showed that the histological follow-
up of uterine cervix samples is necessary in all patients that 
have cytological results of glandular atypia, due to the pos-
sibility of their association with pre-malignant and malig-
nant lesions. The diagnosis of glandular atypia is an exclu-
sion diagnosis, attained when it is not possible to define the 
nature of the lesion, not being possible to be ruled out in 
the cytological assessment. Its increasing incidence is prob-
ably due to a higher degree of observation and training of 
cytologists, collection improvement, as well as the actual in-
crease in cases of glandular lesions. Based on these results, 
it can be observed that cervico-vaginal cytology with AGC 
allows the selection of women that must follow immediately 
to colposcopy and subsequent histological analysis, so that 
an adequate therapeutic conduct can be established, aiming 
at decreasing the rates of cervical cancer. 
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